Kojiro Onizawa Selected Research

Lipopolysaccharides

5/2018

Deletion of both p62 and Nrf2 spontaneously results in the development of nonalcoholic steatohepatitis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kojiro Onizawa Research Topics

Disease

10	Neoplasms (Cancer) 04/2014 - 06/2002
5	Mouth Neoplasms (Oral Cancer) 01/2013 - 02/2003
3	Squamous Cell Carcinoma of Head and Neck 01/2013 - 08/2003
3	Neoplasm Metastasis (Metastasis) 01/2013 - 08/2003
2	Squamous Cell Carcinoma (Epidermoid Carcinoma) 01/2013 - 01/2004
2	Head and Neck Neoplasms (Head and Neck Cancer) 01/2013 - 06/2002
2	Tongue Neoplasms (Tongue Neoplasm) 01/2013 - 01/2004
2	Hyperthermia 01/2013 - 12/2006
2	Lymphatic Metastasis 01/2004 - 06/2002
1	Dysbiosis 05/2018
1	Fatty Liver 05/2018
1	Hepatomegaly 05/2018
1	Herpes Zoster 05/2018
1	Hyperphagia (Overeating) 05/2018
1	Insulin Resistance 05/2018
1	Obesity 05/2018
1	Inflammation (Inflammations) 04/2018
1	Liver Cirrhosis (Hepatic Cirrhosis) 04/2018
1	Carcinoma (Carcinomatosis) 04/2014
1	Neuroleptic Malignant Syndrome 01/2013
1	Pathologic Constriction (Stenosis) 01/2013
1	Delirium 01/2013
1	Emergence Delirium 01/2013
1	Muscle Rigidity 01/2013
1	Cleft Palate (Palate, Cleft) 11/2012
1	Cleft Lip (Harelip) 11/2012
1	Hemangiosarcoma (Angiosarcoma) 09/2012
1	Infections 02/2011
1	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 12/2008
1	Lewis Lung Carcinoma 12/2006
1	Experimental Melanoma 12/2006
1	Necrosis 12/2006
1	Hypercalcemia (Milk Alkali Syndrome) 04/2006

Drug/Important Bio-Agent (IBA)

2	EnzymesIBA 04/2014 - 01/2013
2	alpha-1,6-mannosylglycoprotein beta 1,6-N-acetylglucosaminyltransferaseIBA 04/2014 - 01/2013
2	OligosaccharidesIBA 04/2014 - 01/2013
2	AsparagineIBA 04/2014 - 01/2013
2	Indicators and Reagents (Reagents)IBA 01/2013 - 01/2004
2	Docetaxel (Taxotere)FDA Link 09/2012 - 05/2008
2	PorphyrinsIBA 02/2003 - 06/2002
1	LipopolysaccharidesIBA 05/2018
1	AdipokinesIBA 05/2018
1	Tight Junction ProteinsIBA 05/2018
1	LeptinIBA 04/2018
1	Biomarkers (Surrogate Marker)IBA 04/2018
1	AcetylglucosamineIBA 04/2014
1	Small Interfering RNA (siRNA)IBA 04/2014
1	Proteins (Proteins, Gene)FDA Link 04/2014
1	AntibodiesIBA 01/2013
1	Phosphotransferases (Kinase)IBA 01/2013
1	Haloperidol (Haldol)FDA LinkGeneric 01/2013
1	Chlorpromazine (Thorazine)FDA Link 01/2013
1	Antipsychotic Agents (Antipsychotics)IBA 01/2013
1	Rituximab (Mabthera)FDA Link 12/2008
1	Monoclonal AntibodiesIBA 12/2008
1	CD20 AntigensIBA 12/2008
1	CytokinesIBA 12/2006
1	Diphosphonates (Bisphosphonates)IBA 04/2006
1	VimentinIBA 01/2006
1	Keratin-14 (Keratin 14)IBA 01/2006
1	Heme Oxygenase-1IBA 01/2004
1	Citric Acid (Citrate)FDA LinkGeneric 08/2003
1	gallium citrateIBA 08/2003
1	Technetium (Technetium 99m)IBA 08/2003
1	protoporphyrin IXIBA 02/2003

Therapy/Procedure

3	Therapeutics 02/2011 - 12/2006
2	Neck Dissection (Radical Neck Dissection) 01/2013 - 06/2002
2	Radiotherapy 01/2013 - 01/2006
2	Drug Therapy (Chemotherapy) 05/2008 - 01/2006
1	Chemoradiotherapy 01/2013
1	Nasoalveolar Molding 11/2012
1	General Anesthesia 03/2012
1	Hematopoietic Stem Cell Transplantation 02/2011
1	Aftercare (After-Treatment) 05/2008
1	Immunotherapy 12/2006